Stuart C. Dorman

Stuart C. Dorman

Chief Commercial OfficeratIDEAYA Biosciences· In the 2024 proxy

Pay in FY2024IDEAYA Biosciences stock -27.8% the same year

Stuart C. Dorman was paid $3.4M in FY2024 (Dec). IDEAYA Biosciences stock fell 27.8% that year.

Pay$100 in the stock at the end of FY23 → $72
Pay is from the Summary Compensation Table of each IDEAYA Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IDEAYA BiosciencesPublic company · 2 yr
    • Chief Commercial Officer2024 – Present · 2 yrStock in role -4%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?